Evidence map›Paper›PMID 36915552›Full record

ArticleHeliyon2023

Preventive or promotive effects of

Hideaki Kai, Kenta Teruya, Atsuko Takeuchi, Yoshikazu Nakamura, Hidehiro Mizusawa, Masahito Yamada, Tetsuyuki Kitamoto

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Hideaki KaiDepartment of Neurological Science, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8575, Japan.
Kenta TeruyaDepartment of Neurochemistry, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8575, Japan.
Atsuko TakeuchiDepartment of Neurological Science, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8575, Japan.
Yoshikazu NakamuraDivision of Public Health, Center for Community Medicine, Jichi Medical University, Shimotsuke, Tochigi 329-0498, Japan.
Hidehiro MizusawaDepartment of Neurology, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-0031, Japan.
Masahito YamadaDivision of Neurology, Department of Internal Medicine, Kudanzaka Hospital, Chiyoda-ku, Tokyo 102-0074, Japan.
Tetsuyuki KitamotoDepartment of Neurological Science, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8575, Japan.
Tohoku University · JPJichi Medical University · JPKudanzaka Hospital · JPNational Center of Neurology and Psychiatry · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The polymorphic heterozygosity of

Indexed as

CJD, Creutzfeldt-Jakob diseaseCodon 129Codon 219Creutzfeldt-jakob diseaseDimerE, glutamateElectrostatic interactionGenetic prion diseaseGSS, Gerstmann-Straussler-Scheinker diseaseHeterozygosityK, lysineM, methionineOR, odds ratioPolymorphismPrionPRNPPrP, prion proteinV, valine

Identifiers

PMID36915552
PMCPMC10006469
OpenAlexW4321793735

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read68
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.